Interview with Emily Cheah, General Manager, BRASS
Biomedical Research and Support Services Pte Ltd. is an NUS University spin-off that has been around for more than 14 years; last year the company name was changed to BRASS.…
Address: 33 Ubi Avenue 3,
#06-13/14 Vertex,
Singapore 408868.
33 Ubi Avenue 3, #06-13/14 Vertex, Singapore 408868.
33 Ubi Avenue 3, #06-13/14 Vertex, Singapore 408868.
33 Ubi Avenue 3, #06-13/14 Vertex,,Singapore
Tel: +65 6742 6007
Web: http://www.brass-asiapacific.com/c/
BRASS™ was conceived in the National University of Singapore (NUS) on May 1996 with the primary aim of supporting medical device development from concept into reality.
The brainchild of Assoc. Prof. Eugene Khor, BRASS™ is the answer to the biomedical industry’s need for vital infrastructure in support of the medical devices industry. BRASS™ was registered in December 1997 (hence “SINCE 1997”) and in April 1, 1999, the NUS incubation component of BRASS was granted permission to spin-off as a separate entity.
BRASS™ was awarded sole distributorship for the Charles River Endosafe brand of LAL Bacterial Endotoxin Test reagents in Singapore, Indonesia and Malaysia, an achievement that still remains to this day. With its growing success, BRASS™ was able to secure a partnership with the North American Science Associates, Inc. (NAMSA), the world leader in medical device safety evaluation, in July 2002. With this strategic alliance, BRASS™ is able to provide the full panel of GLP ISO 10993 biocompatibility testing, functional and performance studies, and material characterization to the medical device industry as well as gained the rights to distribute the full series of NAMSA Sterilization Assurance Products in several territories in the Asia Pacific region. In 2011, BRASS™ successfully attained representation for Charles River Biopharmaceutical Services in Singapore, Malaysia, Indonesia and Vietnam.
Thirteen years since its humble beginnings, BRASS™ has grown from strength to strength, and counts as its clients various multinational industry leaders, innovative start-ups and research institutes from the pharmaceutical and medical device industry in South East Asia.
Quality Product Provider: broad range of high quality and reliable media, packaging and sterilization assurance products.
Medical Device Expertise
Specialist in Microbiological Testing
Strategic and customized solutions for product development, regulatory compliance and quality assurance throughout the entire life-cycle of the medical device.
Biomedical Research and Support Services Pte Ltd. is an NUS University spin-off that has been around for more than 14 years; last year the company name was changed to BRASS.…
Eli Lilly and Company General Manager of South ASEAN, Dr. Faiz Ansari speaks about the expanded scope of his role, Lilly’s pipeline, and the approach that Lilly has taken to…
In an exclusive interview with Alan Ong, Executive Vice President of Asia Pacific and Global Head of Medical Devices and Diagnostics at INC Research, he highlights the current trends facing…
In an exclusive interview with Stephen Ooi, Senior Executive Advisor at Zimmer Biomet, he emphasizes the strategic benefits of the global merger between Zimmer and Biomet and how through leveraging…
In an interview with Takeda’s President of Emerging Markets Business Unit, Giles Platford portrays a vitalized focus on emerging markets and explains why those countries are positioned as one of…
Cerner’s managing director of Southeast Asia, Rebecca LaNasa highlights the key importance that Singapore—as the company’s third office outside the U.S.—serves in implementing and piloting new forms of health care…
Recently appointed Senior Vice President of Asia Pacific, Massimiliano Colella speaks about Smith & Nephew’s reasons for establishing a presence in the region, their dual approach in catering to the…
DB Schenker’s director of healthcare in Asia Pacific, Sugantha Natarajan describes the company’s presence across the region, while emphasizing the crucial need for localized solutions in specialized healthcare logistics. She…
In an exclusive interview with Richard Saynor at GSK, he outlines the growth of the CEP portfolio in emerging markets and highlights the opportunities and challenges in the region, as…
Chin Yau Seng, President of Singapore Airlines Cargo, highlights how SIA Cargo supports Singapore’s reputation as a logistics hub in Asia Pacific and how the carrier has been able to…
Paul Bruhn, Regional Business Head Asia, Oceania, MEA of Nestlé Health Science in Singapore, elaborates on the intricacies of these diverse regions and the strategic importance of Singapore as a…
The founder and CEO of Vela Diagnostics, Michael Tillmann underscores the motivating drivers behind the establishment of the company and how their unique portfolio of automated PCR and NGS solutions…
HGP Partner and Director of Asia, Ming Chua on the company’s reasons for using Singapore as the first point of entry into Asia, while highlighting the expansion of the country’s…
See our Cookie Privacy Policy Here
